[VIVO] YoY Annual Result on 30-Sep-2017 [#FY]

Stock
[VIVO] Meridian Bioscience, Inc.
Announcement Date
29-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#FY]
Profit Trend
YoY- -33.11%
Quarter Report
VIVO's Result
VIVO's Financial Summary
View:
Show?
Annual Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 253,667 201,014 213,571 200,771 196,082 194,830 188,832 5.03%
PBT 59,293 31,557 30,380 36,429 50,644 55,063 52,108 2.17%
Tax 13,107 7,175 6,531 14,872 18,415 19,523 17,365 -4.57%
NP 46,186 24,382 23,849 21,557 32,229 35,540 34,743 4.85%
Tax Rate -22.11% -22.74% -21.50% -40.82% -36.36% -35.46% -33.33% -
Total Cost 207,481 176,632 189,722 179,214 163,853 159,290 154,089 5.07%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin 18.21 12.13 11.17 10.74 16.44 18.24 18.40 -0.17%
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS 1.07 0.57 0.56 0.51 0.77 0.85 0.84 4.11%
EPS Diluted 1.07 0.57 0.56 0.51 0.76 0.85 0.83 4.31%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.